Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Kara

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Drug Safety|May 20, 2025
The Role of Adverse Event Follow-Up in Advancing the Knowledge of Medicines and Vaccines Safety: A Scoping ReviewVijay Kara, Florence Van Hunsel, Andrew Bate, et al.
Frontiers in Pharmacology|June 20, 2022
Engaging Patients <i>via</i> Online Healthcare Fora: Three Pharmacovigilance Use CasesGreg Powell, Vijay Kara, Jeffery L Painter, et al.
Drug Safety|August 3, 2023
Finding Needles in the Haystack: Clinical Utility Score for Prioritisation (CUSP), an Automated Approach for Identifying Spontaneous Reports with the Highest Clinical UtilityVijay Kara, Greg Powell, Olivia Mahaux, et al.
Scientific Reports|July 30, 2025
The need for guardrails with large language models in pharmacovigilance and other medical safety critical settingsJoe B Hakim, Jeffery L Painter, Darmendra Ramcharran, et al.
Drug Safety|December 24, 2022
Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission NetworksJohn van Stekelenborg, Vijay Kara, Roman Haack, et al.
Therapeutic Innovation & Regulatory Science|November 17, 2024
Testing the Feasibility of a Digital Point of Care Solution for the Trusted Near Real-Time Bidirectional Exchange of Novel and Informative Adverse Event InformationGreg Powell, Vijay Kara, Daniel Naranjo, et al.
Therapeutic Advances in Drug Safety|December 23, 2025
Orchestrating generative AI in pharmacovigilance: predicting and preempting the unpredictableDarmendra Ramcharran, Jeffery L Painter, Vijay Kara, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drug Safety|May 20, 2025
The Role of Adverse Event Follow-Up in Advancing the Knowledge of Medicines and Vaccines Safety: A Scoping ReviewVijay Kara, Florence Van Hunsel, Andrew Bate, et al.
Frontiers in Pharmacology|June 20, 2022
Engaging Patients <i>via</i> Online Healthcare Fora: Three Pharmacovigilance Use CasesGreg Powell, Vijay Kara, Jeffery L Painter, et al.
Drug Safety|August 3, 2023
Finding Needles in the Haystack: Clinical Utility Score for Prioritisation (CUSP), an Automated Approach for Identifying Spontaneous Reports with the Highest Clinical UtilityVijay Kara, Greg Powell, Olivia Mahaux, et al.
Scientific Reports|July 30, 2025
The need for guardrails with large language models in pharmacovigilance and other medical safety critical settingsJoe B Hakim, Jeffery L Painter, Darmendra Ramcharran, et al.
Drug Safety|December 24, 2022
Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission NetworksJohn van Stekelenborg, Vijay Kara, Roman Haack, et al.
Therapeutic Innovation & Regulatory Science|November 17, 2024
Testing the Feasibility of a Digital Point of Care Solution for the Trusted Near Real-Time Bidirectional Exchange of Novel and Informative Adverse Event InformationGreg Powell, Vijay Kara, Daniel Naranjo, et al.
Therapeutic Advances in Drug Safety|December 23, 2025
Orchestrating generative AI in pharmacovigilance: predicting and preempting the unpredictableDarmendra Ramcharran, Jeffery L Painter, Vijay Kara, et al.
Pageof 1